| 1 |
20058135 | UFT and S-1 for treatment of primary lung cancer. | 2010 Jan |
1 |
| 2 |
16685161 | [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients]. | 2006 May |
2 |
| 3 |
15984520 | [Phase I study of concurrent radiotherapy with TS-1 and vitamin A (TAR Therapy) for head and neck cancer]. | 2005 Jun |
1 |
| 4 |
16080558 | Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidine. | 2005 Jul-Aug |
1 |
| 5 |
12616366 | Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma. | 2003 |
1 |
| 6 |
12775023 | Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines. | 2003 |
2 |
| 7 |
12040690 | [The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer]. | 2002 May |
1 |
| 8 |
11098485 | Oral DPD-inhibitory fluoropyrimidine drugs. | 2000 Oct |
1 |
| 9 |
10442353 | Clinical implications of dihydropyrimidine dehydrogenase inhibition. | 1999 Jul |
2 |